Vaneck Biotech Etf Market Value
| BBH Etf | USD 165.82 1.85 1.13% |
| Symbol | VanEck |
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
VanEck Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VanEck Biotech's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VanEck Biotech.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in VanEck Biotech on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding VanEck Biotech ETF or generate 0.0% return on investment in VanEck Biotech over 30 days. VanEck Biotech is related to or competes with Global X, Global X, Global X, and Global X. The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index More
VanEck Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VanEck Biotech's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess VanEck Biotech ETF upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.26) | |||
| Maximum Drawdown | 6.02 | |||
| Value At Risk | (1.87) | |||
| Potential Upside | 1.23 |
VanEck Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for VanEck Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VanEck Biotech's standard deviation. In reality, there are many statistical measures that can use VanEck Biotech historical prices to predict the future VanEck Biotech's volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.32) | |||
| Treynor Ratio | (0.20) |
VanEck Biotech ETF Backtested Returns
VanEck Biotech ETF owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the etf had a -0.13% return per unit of risk over the last 3 months. VanEck Biotech ETF exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VanEck Biotech's Coefficient Of Variation of (726.99), variance of 1.07, and Risk Adjusted Performance of (0.10) to confirm the risk estimate we provide. The entity has a beta of 0.75, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, VanEck Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding VanEck Biotech is expected to be smaller as well.
Auto-correlation | 0.13 |
Insignificant predictability
VanEck Biotech ETF has insignificant predictability. Overlapping area represents the amount of predictability between VanEck Biotech time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VanEck Biotech ETF price movement. The serial correlation of 0.13 indicates that less than 13.0% of current VanEck Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 24.21 |
VanEck Biotech ETF lagged returns against current returns
Autocorrelation, which is VanEck Biotech etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting VanEck Biotech's etf expected returns. We can calculate the autocorrelation of VanEck Biotech returns to help us make a trade decision. For example, suppose you find that VanEck Biotech has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
VanEck Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If VanEck Biotech etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if VanEck Biotech etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in VanEck Biotech etf over time.
Current vs Lagged Prices |
| Timeline |
VanEck Biotech Lagged Returns
When evaluating VanEck Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of VanEck Biotech etf have on its future price. VanEck Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, VanEck Biotech autocorrelation shows the relationship between VanEck Biotech etf current value and its past values and can show if there is a momentum factor associated with investing in VanEck Biotech ETF.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:Check out VanEck Biotech Correlation, VanEck Biotech Volatility and VanEck Biotech Alpha and Beta module to complement your research on VanEck Biotech. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
VanEck Biotech technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.